Invesco’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
653,949
+319,692
+96% +$550K ﹤0.01% 2797
2025
Q1
$1.11M Buy
334,257
+112,329
+51% +$374K ﹤0.01% 2780
2024
Q4
$1.64M Buy
221,928
+4,967
+2% +$36.8K ﹤0.01% 2682
2024
Q3
$2.04M Buy
216,961
+2,892
+1% +$27.2K ﹤0.01% 2583
2024
Q2
$1.72M Sell
214,069
-2,729
-1% -$21.9K ﹤0.01% 2649
2024
Q1
$3.21M Sell
216,798
-620,360
-74% -$9.19M ﹤0.01% 2451
2023
Q4
$6.81M Buy
837,158
+686,067
+454% +$5.58M ﹤0.01% 2059
2023
Q3
$687K Buy
151,091
+6,453
+4% +$29.4K ﹤0.01% 3035
2023
Q2
$1.02M Buy
144,638
+2,449
+2% +$17.2K ﹤0.01% 2880
2023
Q1
$869K Buy
142,189
+45,375
+47% +$277K ﹤0.01% 2947
2022
Q4
$619K Sell
96,814
-364
-0.4% -$2.33K ﹤0.01% 3159
2022
Q3
$931K Sell
97,178
-1,541,077
-94% -$14.8M ﹤0.01% 2942
2022
Q2
$18.1M Sell
1,638,255
-23,037
-1% -$254K 0.01% 1431
2022
Q1
$27.7M Buy
1,661,292
+74,225
+5% +$1.24M 0.01% 1294
2021
Q4
$30.3M Buy
1,587,067
+560,410
+55% +$10.7M 0.01% 1288
2021
Q3
$25.3M Sell
1,026,657
-7,708
-0.7% -$190K 0.01% 1425
2021
Q2
$26.9M Sell
1,034,365
-133,507
-11% -$3.47M 0.01% 1414
2021
Q1
$37M Sell
1,167,872
-437,391
-27% -$13.8M 0.01% 1202
2020
Q4
$74.5M Buy
1,605,263
+27,447
+2% +$1.27M 0.02% 872
2020
Q3
$51.9M Buy
1,577,816
+352,995
+29% +$11.6M 0.02% 925
2020
Q2
$33.6M Buy
1,224,821
+1,040,995
+566% +$28.6M 0.01% 1072
2020
Q1
$5.5M Buy
183,826
+67,895
+59% +$2.03M ﹤0.01% 1821
2019
Q4
$3.21M Buy
+115,931
New +$3.21M ﹤0.01% 2415
2019
Q3
Sell
-133,591
Closed -$3.28M 3645
2019
Q2
$3.28M Buy
+133,591
New +$3.28M ﹤0.01% 2424
2018
Q3
Sell
-315,330
Closed -$4.04M 3849
2018
Q2
$4.04M Buy
+315,330
New +$4.04M ﹤0.01% 2274
2015
Q3
Sell
-569
Closed -$5K 3852
2015
Q2
$5K Buy
+569
New +$5K ﹤0.01% 4201